Melinta Therapeutics to Present at BioCentury Future Leaders Conference
Mar 03, 2016 13:00 pm UTC| Business
NEW HAVEN, Conn., March 03, 2016 -- Melinta Therapeutics today announced that Dr. Eugene Sun, the Company’s interim Chief Executive Officer, will present a clinical and corporate update at BioCentury’s 23rd annual...
Mar 03, 2016 13:00 pm UTC| Business
NEW YORK, March 03, 2016 -- UNITED STATES DISTRICT COURTDISTRICT OF OREGON IN RE GALENA BIOPHARMA, INC. SECURITIES LITIGATION, Case No.:3:14-cv-00367-SI SUMMARY NOTICE OF PROPOSED PARTIAL SETTLEMENT OF CLASS...
UBIC Enhances Its “PATENT EXPLORER” Analysis System
Mar 03, 2016 12:55 pm UTC| Business
TOKYO, March 03, 2016 -- UBIC, Inc. (Nasdaq:UBIC) (TSE:2158) ("UBIC" or "the Company"), a leading provider of artificial intelligence (AI)-based big data analysis services, announced today that it has enhanced Lit i...
Dermira Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update
Mar 03, 2016 12:30 pm UTC| Business
MENLO PARK, Calif., March 03, 2016 -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to identifying, developing and commercializing innovative, differentiated therapies to improve the lives of...
Provision Interactive Continues to Expand Its Retail Presence
Mar 03, 2016 12:30 pm UTC| Business
CHATSWORTH, Calif., March 03, 2016 -- Provision Interactive Technologies, Inc. ("Provision"), a subsidiary of Provision Holding, Inc. (OTCQB:PVHO) announced today that it has shipped an additional 24 3D Savings Center...
Mar 03, 2016 12:30 pm UTC| Business
SAN DIEGO, March 03, 2016 -- Otonomy, Inc.(NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear,today announced the...
Cancer Genetics to Report Fourth Quarter & Fiscal 2015 Financial Results on Thursday, March 10
Mar 03, 2016 12:30 pm UTC| Business
RUTHERFORD, N.J., March 03, 2016 -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, announced today that it will report financial...